{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:03:24Z","timestamp":1770419004071,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"publisher","award":["1029"],"award-info":[{"award-number":["1029"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00705-020-04900-3","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T23:03:06Z","timestamp":1609974186000},"page":"545-557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model"],"prefix":"10.1007","volume":"166","author":[{"given":"Ailar","family":"Sabbaghi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3108-5655","authenticated-orcid":false,"given":"Mohsen","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farahnaz","family":"Motamedi-Sedeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7793-2920","authenticated-orcid":false,"given":"Amir","family":"Ghaemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"issue":"6","key":"4900_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1099\/vir.0.018168-0","volume":"91","author":"Y Furuya","year":"2010","unstructured":"Furuya Y, Regner M, Lobigs M, Koskinen A, M\u00fcllbacher A, Alsharifi M (2010) Effect of inactivation method on the cross-protective immunity induced by whole \u2018killed\u2019influenza A viruses and commercial vaccine preparations. J Gen Virol 91(6):1450\u20131460","journal-title":"J Gen Virol"},{"issue":"2","key":"4900_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/icb.1988.19","volume":"66","author":"A M\u00fcllbacher","year":"1998","unstructured":"M\u00fcllbacher A, Ada G, Tha Hla R (1998) Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol 66(2):153\u2013157","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"4900_CR3","doi-asserted-by":"publisher","first-page":"e5336","DOI":"10.1371\/journal.pone.0005336","volume":"4","author":"M Alsharifi","year":"2009","unstructured":"Alsharifi M, Furuya Y, Bowden TR, Lobigs M, Koskinen A, Regner M, Trinidad L, Boyle DB, M\u00fcllbacher A (2009) Intranasal flu vaccine protective against seasonal and H5N1 avian influenza infections. PLoS ONE 4(4):e5336","journal-title":"PLoS ONE"},{"issue":"10","key":"4900_CR4","doi-asserted-by":"publisher","first-page":"e25765","DOI":"10.1371\/journal.pone.0025765","volume":"6","author":"Y Furuya","year":"2011","unstructured":"Furuya Y, Chan J, Wan EC, Koskinen A, Diener KR, Hayball JD, Regner M, M\u00fcllbacher A, Alsharifi M (2011) Gamma-irradiated influenza virus uniquely induces IFN-I mediated lymphocyte activation independent of the TLR7\/MyD88 pathway. PLoS ONE 6(10):e25765","journal-title":"PLoS ONE"},{"issue":"2","key":"4900_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/icb.2009.81","volume":"88","author":"M Alsharifi","year":"2010","unstructured":"Alsharifi M, M\u00fcllbacher A (2010) The [gamma]-irradiated influenza vaccine and the prospect of producing safe vaccines in general. Immunol Cell Biol 88(2):103","journal-title":"Immunol Cell Biol"},{"issue":"7","key":"4900_CR6","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.vaccine.2016.12.044","volume":"35","author":"SC David","year":"2017","unstructured":"David SC, Lau J, Singleton EV, Babb R, Davies J, Hirst TR, McColl SR, Paton JC, Alsharifi M (2017) The effect of gamma-irradiation conditions on the immunogenicity of whole-inactivated influenza A virus vaccine. Vaccine 35(7):1071\u20131079","journal-title":"Vaccine"},{"issue":"11","key":"4900_CR7","doi-asserted-by":"publisher","first-page":"e319","DOI":"10.3390\/v8110319","volume":"8","author":"J Fertey","year":"2016","unstructured":"Fertey J, Bayer L, Grunwald T, Pohl A, Beckmann J, Gotzmann G, Casado JP, Sch\u00f6nfelder J, R\u00f6gner FH, Wetzel C, Thoma M (2016) Pathogens inactivated by low-energy-electron irradiation maintain antigenic properties and induce protective immune responses. Viruses 8(11):e319","journal-title":"Viruses"},{"issue":"27","key":"4900_CR8","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1016\/j.vaccine.2018.05.093","volume":"36","author":"J Astill","year":"2018","unstructured":"Astill J, Alkie T, Yitbarek A, Taha-Abdelaziz K, Bavananthasivam J, Nagy \u00c9, Petrik JJ, Sharif S (2018) Examination of the effects of virus inactivation methods on the induction of antibody-and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens. Vaccine 36(27):3908\u20133916","journal-title":"Vaccine"},{"issue":"12","key":"4900_CR9","doi-asserted-by":"publisher","first-page":"e1004556","DOI":"10.1371\/journal.ppat.1004556","volume":"10","author":"A Egli","year":"2014","unstructured":"Egli A, Santer DM, O\u2019Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, Lisboa LF (2014) IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog 10(12):e1004556","journal-title":"PLoS Pathog"},{"issue":"7","key":"4900_CR10","doi-asserted-by":"publisher","first-page":"e0159153","DOI":"10.1371\/journal.pone.0159153","volume":"11","author":"S Cardenas-Garcia","year":"2016","unstructured":"Cardenas-Garcia S, Dunwoody RP, Marcano V, Diel DG, Williams RJ, Gogal RM Jr, Brown CC, Miller PJ, Afonso CL (2016) Effects of chicken interferon gamma on newcastle disease virus vaccine immunogenicity. PLoS ONE 11(7):e0159153","journal-title":"PLoS ONE"},{"key":"4900_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.vetmic.2019.05.015","volume":"234","author":"L Gan","year":"2019","unstructured":"Gan L, Tian Y, Zhao Y, Xq S, Zhou W, Xia BB, Chen J, Wang ML, Zhao J (2019) Enhancing immunogenicity and protective efficacy of inactivated avian influenza H9N2 vaccine with recombinant chicken IFN-\u03b1 in chicken. Vet Microbiol 234:77\u201382","journal-title":"Vet Microbiol"},{"issue":"1","key":"4900_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.4049\/jimmunol.169.1.375","volume":"169","author":"E Proietti","year":"2002","unstructured":"Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, Venditti M, Capone I, Seif I, De Maeyer E, Tough D (2002) Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model. J Immunol 169(1):375\u2013383","journal-title":"J Immunol"},{"issue":"1","key":"4900_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2014.51","volume":"3","author":"A Egli","year":"2014","unstructured":"Egli A, Santer DM, O\u2019Shea D, Tyrrell DL, Houghton M (2014) The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections. Emerg Microbes Infect 3(1):1\u201312","journal-title":"Emerg Microbes Infect"},{"issue":"21","key":"4900_CR14","doi-asserted-by":"publisher","first-page":"11515","DOI":"10.1128\/JVI.01703-09","volume":"84","author":"NA Jewell","year":"2010","unstructured":"Jewell NA, Cline T, Mertz SE, Smirnov SV, Fla\u00f1o E, Schindler C, Grieves JL, Durbin RK, Kotenko SV, Durbin JE (2010) Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. J Virol 84(21):11515\u201311522","journal-title":"J Virol"},{"issue":"2","key":"4900_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/gene.2008.87","volume":"10","author":"C Dellgren","year":"2009","unstructured":"Dellgren C, Gad HH, Hamming O, Melchjorsen J, Hartmann R (2009) Human interferon-\u03bb3 is a potent member of the type III interferon family. Genes Immun 10(2):125\u2013131","journal-title":"Genes Immun"},{"issue":"4","key":"4900_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.26657","volume":"59","author":"CR Bolen","year":"2014","unstructured":"Bolen CR, Ding S, Robek MD, Kleinstein SH (2014) Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression. Hepatol 59(4):1262\u20131272","journal-title":"Hepatol"},{"issue":"6","key":"4900_CR17","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1099\/vir.0.80904-0","volume":"86","author":"NW Bartlett","year":"2005","unstructured":"Bartlett NW, Buttigieg K, Kotenko SV, Smith GL (2005) Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol 86(6):1589\u20131596","journal-title":"J Gen Virol"},{"issue":"9","key":"4900_CR18","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","volume":"80","author":"N Ank","year":"2006","unstructured":"Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR (2006) Lambda interferon (IFN-\u03bb), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 80(9):4501\u20134509","journal-title":"J Virol"},{"issue":"8","key":"4900_CR19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/vim.2017.0033","volume":"30","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Wang Z, Xu Y, Zhang Z, Hua R, Liu W, Jiang C, Chen Y, Yang W, Kong W (2017) Optimized DNA vaccine enhanced by adjuvant IL28B induces protective immune responses against herpes simplex virus type 2 in mice. Viral Immunol 30(8):601\u2013614","journal-title":"Viral Immunol"},{"issue":"23","key":"4900_CR20","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1182\/blood-2008-11-190520","volume":"113","author":"MP Morrow","year":"2009","unstructured":"Morrow MP, Pankhong P, Laddy DJ, Schoenly KA, Yan J, Cisper N, Weiner DB (2009) Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity. Blood 113(23):5868\u20135877","journal-title":"Blood"},{"issue":"2","key":"4900_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan MA (2016) Determination of 50% endpoint titer using a simple formula. World J Virol 5(2):85\u201386","journal-title":"World J Virol"},{"issue":"3","key":"4900_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000433538","volume":"58","author":"F Motamedi-Sedeh","year":"2015","unstructured":"Motamedi-Sedeh F, Soleimanjahi H, Jalilian AR, Mahravani H, Shafaee K, Sotoodeh M, Taherkarami H, Jairani F (2015) Development of protective immunity against inactivated iranian isolate of foot-and-mouth disease virus type O\/IRN\/2007 using gamma ray-irradiated vaccine on BALB\/c mice and guinea pigs. Intervirology 58(3):190\u2013196","journal-title":"Intervirology"},{"issue":"1","key":"4900_CR23","doi-asserted-by":"publisher","first-page":"15G","DOI":"10.1002\/0471729256.mc15g01s3","volume":"3","author":"KJ Szretter","year":"2006","unstructured":"Szretter KJ, Balish AL, Katz JM (2006) Influenza: propagation, quantification, and storage. Curr Protoc Microbiol 3(1):15G-G21","journal-title":"Curr Protoc Microbiol"},{"issue":"23","key":"4900_CR24","doi-asserted-by":"publisher","first-page":"8676","DOI":"10.1073\/pnas.0402486101","volume":"101","author":"Q Ge","year":"2004","unstructured":"Ge Q, Filip L, Bai A, Nguyen T, Eisen HN, Chen J (2004) Inhibition of influenza virus production in virus-infected mice by RNA interference. PNAS 101(23):8676\u20138681","journal-title":"PNAS"},{"issue":"5","key":"4900_CR25","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00705-017-3230-7","volume":"162","author":"F Fotouhi","year":"2017","unstructured":"Fotouhi F, Shaffifar M, Farahmand B, Shirian S, Saeidi M, Tabarraei A, Gorji A, Ghaemi A (2017) Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Arch Virol 162(5):1251\u20131260","journal-title":"Arch Virol"},{"issue":"3","key":"4900_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12250-013-3291-z","volume":"28","author":"M Naderi","year":"2013","unstructured":"Naderi M, Saeedi A, Moradi A, Kleshadi M, Zolfaghari MR, Gorji A, Ghaemi A (2013) Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity. Virolo Sin 28(3):167\u2013173","journal-title":"Virolo Sin"},{"issue":"1","key":"4900_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-3083.2005.01633.x","volume":"62","author":"AO Hovden","year":"2005","unstructured":"Hovden AO, Cox R, Haaheim L (2005) Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB\/c mice. Scand J Immunol 62(1):36\u201344","journal-title":"Scand J Immunol"},{"issue":"11","key":"4900_CR28","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1128\/JVI.75.11.5141-5150.2001","volume":"75","author":"TM Tumpey","year":"2001","unstructured":"Tumpey TM, Renshaw M, Clements JD, Katz JM (2001) Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J Virol 75(11):5141\u20135150","journal-title":"J Virol"},{"issue":"23\u201324","key":"4900_CR29","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/pmic.201300096","volume":"13","author":"YM She","year":"2013","unstructured":"She YM, Cheng K, Farnsworth A, Li X, Cyr TD (2013) Surface modifications of influenza proteins upon virus inactivation by \u03b2-propiolactone. Proteomics 13(23\u201324):3537\u20133547","journal-title":"Proteomics"},{"issue":"1","key":"4900_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.chom.2012.05.011","volume":"12","author":"EK Gaidamakova","year":"2012","unstructured":"Gaidamakova EK, Myles IA, McDaniel DP, Fowler CJ, Valdez PA, Naik S, Gayen M, Gupta P, Sharma A, Glass PJ, Maheshwari RK (2012) Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio-protective Mn2+-Peptide complex from Deinococcus. Cell Host Microbe 12(1):117\u2013124","journal-title":"Cell Host Microbe"},{"issue":"94","key":"4900_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejpb.2015.05.023","volume":"1","author":"PC Soema","year":"2015","unstructured":"Soema PC, Kompier R, Amorij JP, Kersten GF (2015) Current and next generation influenza vaccines: formulation and production strategies. Eur J Pharm Biopharm 1(94):251\u2013263","journal-title":"Eur J Pharm Biopharm"},{"key":"4900_CR32","doi-asserted-by":"publisher","first-page":"e1000017","DOI":"10.1371\/journal.ppat.1000017","volume":"4","author":"C Sommereyns","year":"2008","unstructured":"Sommereyns C, Paul S, Staeheli P, Michiels T (2008) IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo. PLoS Pathog 4:e1000017","journal-title":"PLoS Pathog"},{"key":"4900_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fmicb.2017.00900","volume":"8","author":"VM Gould","year":"2017","unstructured":"Gould VM, Francis JN, Anderson KJ, Georges B, Cope AV, Tregoning JS (2017) Nasal IgA provides protection against human influenza challenge in volunteers with low serum influenza antibody titre. Front Microbiol 8:900","journal-title":"Front Microbiol"},{"issue":"3","key":"4900_CR34","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","volume":"173","author":"KB Renegar","year":"2004","unstructured":"Renegar KB, Small PA, Boykins LG, Wright PF (2004) Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 173(3):1978\u20131986","journal-title":"J Immunol"},{"issue":"6","key":"4900_CR35","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1128\/IAI.67.6.2884-2890.1999","volume":"67","author":"A Rudin","year":"1999","unstructured":"Rudin A, Riise GC, Holmgren J (1999) Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun 67(6):2884\u20132890","journal-title":"Infect Immun"},{"issue":"1","key":"4900_CR36","doi-asserted-by":"publisher","first-page":"e14538","DOI":"10.1371\/journal.pone.0014538","volume":"6","author":"JM Song","year":"2011","unstructured":"Song JM, Wang BZ, Park KM, Van Rooijen N, Quan F-S, Kim MC, Jin HT, Pekosz A, Compans RW, Kang SM (2011) Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS ONE 6(1):e14538","journal-title":"PLoS ONE"},{"issue":"10","key":"4900_CR37","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/eji.201243018","volume":"43","author":"SN Lauder","year":"2013","unstructured":"Lauder SN, Jones E, Smart K, Bloom A, Williams AS, Hindley JP, Ondondo B, Taylor PR, Clement M, Fielding C, Godkin AJ (2013) Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol 43(10):2613\u20132625","journal-title":"Eur J Immunol"},{"issue":"12","key":"4900_CR38","doi-asserted-by":"publisher","first-page":"e28680","DOI":"10.1371\/journal.pone.0028680","volume":"6","author":"X Yu","year":"2011","unstructured":"Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, Shao J, Shen J, Gao Y, Yuan Z, Wu F (2011) Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLoS ONE 6(12):e28680","journal-title":"PLoS ONE"},{"issue":"3","key":"4900_CR39","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jmv.1045","volume":"64","author":"L Kaiser","year":"2001","unstructured":"Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG (2001) Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 64(3):262\u2013268","journal-title":"J Med Virol"},{"issue":"5","key":"4900_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1128\/CDLI.5.5.604-608.1998","volume":"5","author":"D Gentile","year":"1998","unstructured":"Gentile D, Doyle W, Whiteside T, Fireman P, Hayden FG, Skoner D (1998) Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin Diagn Lab Immunol 5(5):604\u2013608","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"4900_CR41","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1086\/314938","volume":"180","author":"RS Fritz","year":"1999","unstructured":"Fritz RS, Hayden FG, Calfee DP, Cass LM, Peng AW, Alvord WG, Strober W, Straus SE (1999) Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. J Infect Dis 180(3):586\u2013593","journal-title":"J Infect Dis"},{"issue":"4","key":"4900_CR42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/088282402320914520","volume":"15","author":"K Van Reeth","year":"2002","unstructured":"Van Reeth K, Van Gucht S, Pensaert M (2002) Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol 15(4):583\u2013594","journal-title":"Viral Immunol"},{"issue":"7","key":"4900_CR43","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1128\/JVI.02052-06","volume":"81","author":"FS Quan","year":"2007","unstructured":"Quan FS, Huang C, Compans RW, Kang SM (2007) Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 81(7):3514\u20133524","journal-title":"J Virol"},{"issue":"10","key":"4900_CR44","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.1128\/JVI.02408-09","volume":"84","author":"K Sun","year":"2010","unstructured":"Sun K, Torres L, Metzger DW (2010) A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J Virol 84(10):5007\u20135014","journal-title":"J Virol"},{"issue":"3","key":"4900_CR45","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nm.1929","volume":"15","author":"J Sun","year":"2009","unstructured":"Sun J, Madan R, Karp CL, Braciale TJ (2009) Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15(3):277\u2013284","journal-title":"Nat Med"},{"issue":"12","key":"4900_CR46","doi-asserted-by":"publisher","first-page":"7353","DOI":"10.4049\/jimmunol.0900657","volume":"182","author":"KK McKinstry","year":"2009","unstructured":"McKinstry KK, Strutt TM, Buck A, Curtis JD, Dibble JP, Huston G, Tighe M, Hamada H, Sell S, Dutton RW, Swain SL (2009) IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol 182(12):7353\u20137363","journal-title":"J Immunol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-020-04900-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04900-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:44:23Z","timestamp":1744181063000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-020-04900-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4900"],"URL":"https:\/\/doi.org\/10.1007\/s00705-020-04900-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"16 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experiments were performed according to the Ethics Committee for the Use and Care of Laboratory Animals of Islamic Azad University, Tehran Medical Branch, Iran (ethics number: IR.IAU.TMU.REC.1397.309).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}